Tsuneo Takenaka1, Tsutomu Inoue2, Takashi Miyazaki2, Hiroyuki Kobori1, Akira Nishiyama3, Naohito Ishii4, Matsuhiko Hayashi5, Hiromichi Suzuki2. 1. Department of Medicine, International University of Health and Welfare, 8-10-16 Akasaka, Minato, Tokyo 107-0052, Japan. 2. Department of Nephrology, Saitama Medical University, Iruma, Saitama, Japan. 3. Department of Pharmacology, Kagawa University, Kida, Kagawa, Japan. 4. Department of Clinical Chemistry, Kitasato University, Sagamihara, Kanagawa, Japan. 5. Blood Purification Center, Keio University, Shinjuku, Tokyo, Japan.
Abstract
BACKGROUNDS: Klotho protein interacts with the transforming growth factor β (TGF-β) receptor and Wnt, which contribute to the progression of renal disease, inhibiting their signals. Renal and circulating klotho levels are diminished in chronic kidney disease. METHODS: Experiments were performed to assess whether supplementation of klotho protein could have protective effects on the kidney. Rats were injected with adriamycin (5 mg/kg) and divided into three groups: those treated with vehicle, those treated with klotho protein and those treated with klotho plus 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (TDZD). Rats without adriamycin treatment were used as a control. RESULTS: Adriamycin reduced the serum klotho concentration and renal expression of klotho and E-cadherin. Adriamycin also increased the renal expression of Wnt, TGF-β, and angiotensinogen, as well as the renal abundance of β-catenin and angiotensin II. Klotho supplementation suppressed adriamycin-induced elevations of β-catenin and angiotensin II with sustained Wnt expression. Combined treatment with klotho and TDZD reversed the klotho-induced improvements in the renal abundance of β-catenin and angiotensin II as well as the expression of TGF-β and angiotensinogen without affecting E-cadherin. CONCLUSIONS: Our data indicate that Wnt is involved in the pathogenesis of adriamycin nephropathy. Furthermore, klotho supplementation inhibited Wnt signaling, ameliorating renal angiotensin II. Finally, klotho protein appears to suppress epithelial-mesenchymal transition by inhibiting TGF-β and Wnt signaling.
BACKGROUNDS: Klotho protein interacts with the transforming growth factor β (TGF-β) receptor and Wnt, which contribute to the progression of renal disease, inhibiting their signals. Renal and circulating klotho levels are diminished in chronic kidney disease. METHODS: Experiments were performed to assess whether supplementation of klotho protein could have protective effects on the kidney. Rats were injected with adriamycin (5 mg/kg) and divided into three groups: those treated with vehicle, those treated with klotho protein and those treated with klotho plus 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (TDZD). Rats without adriamycin treatment were used as a control. RESULTS: Adriamycin reduced the serum klotho concentration and renal expression of klotho and E-cadherin. Adriamycin also increased the renal expression of Wnt, TGF-β, and angiotensinogen, as well as the renal abundance of β-catenin and angiotensin II. Klotho supplementation suppressed adriamycin-induced elevations of β-catenin and angiotensin II with sustained Wnt expression. Combined treatment with klotho and TDZD reversed the klotho-induced improvements in the renal abundance of β-catenin and angiotensin II as well as the expression of TGF-β and angiotensinogen without affecting E-cadherin. CONCLUSIONS: Our data indicate that Wnt is involved in the pathogenesis of adriamycin nephropathy. Furthermore, klotho supplementation inhibited Wnt signaling, ameliorating renal angiotensin II. Finally, klotho protein appears to suppress epithelial-mesenchymal transition by inhibiting TGF-β and Wnt signaling.
Authors: Y Kato; E Arakawa; S Kinoshita; A Shirai; A Furuya; K Yamano; K Nakamura; A Iida; H Anazawa; N Koh; A Iwano; A Imura; T Fujimori; M Kuro-o; N Hanai; K Takeshige; Y Nabeshima Journal: Biochem Biophys Res Commun Date: 2000-01-19 Impact factor: 3.575
Authors: Andreas D Kistler; Geetika Singh; Mehmet M Altintas; Hao Yu; Isabel C Fernandez; Changkyu Gu; Cory Wilson; Sandeep Kumar Srivastava; Alexander Dietrich; Katherina Walz; Dontscho Kerjaschki; Phillip Ruiz; Stuart Dryer; Sanja Sever; Amit K Dinda; Christian Faul; Jochen Reiser Journal: J Biol Chem Date: 2013-11-05 Impact factor: 5.157
Authors: Hongjun Liu; Maria M Fergusson; Rogerio M Castilho; Jie Liu; Liu Cao; Jichun Chen; Daniela Malide; Ilsa I Rovira; Daniel Schimel; Calvin J Kuo; J Silvio Gutkind; Paul M Hwang; Toren Finkel Journal: Science Date: 2007-08-10 Impact factor: 47.728